RewordedRisk Factors
Our investment portfolio may be adversely affected as a result of any delays or failures of borrowers to make payments of principal and interest when due or delays or moratoriums on foreclosures, enforcement actions with respect to delinquent or defaulted mortgages imposed by governmental authorities or the failure of tenants to pay rent or tenants' demands for lease modifications. due.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
We cannot predict the requirements of the regulations ultimately whether other federal initiatives will be adopted or what impact, if any, such initiatives, if adopted, the effect such regulations will may have on financial markets generally, or on our businesses specifically, the additional costs associated with compliance with such initiatives and related regulations, or any changes to our operations that may be necessary to comply with any new regulations, any of which could have a material adverse effect on our business, results of operations, cash flows or financial condition.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
The relative newness of the technology, the speed at which it is being adopted, and the relative lack of laws, regulations or standards expressly and specifically governing its use use, combined with the growing interest by various legislators and regulators to address the development and deployment of AI technologies in a manner which may not be consistent across jurisdictions, increases these risks.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
(i) CNO Bermuda Re's statutory economic capital and surplus is less than 150 percent of its ECR at the end of any calendar quarter; or (ii) CNO Bermuda Re's liquid assets are insufficient to meet its contractual obligations to ceding insurers, in each case, unless Bankers Life one or more ceding insurers has provided notice of recapture pursuant to the terms of a modified coinsurance the applicable reinsurance agreement between it and CNO Bermuda Re. Re and such recapture will cause CNO Bermuda Re to meet (i) and (ii) above.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
In addition, we have, under an intercompany reinsurance agreement agreements initiated in 2023, 2023 and 2025, ceded approximately $7.6 $8.8 billion of our fixed indexed annuity statutory reserves from Bankers Life and approximately $1.9 billion of our supplemental health statutory reserves from Washington National, respectively, to CNO Bermuda Re as of December 31, 2024. 2025.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
Certain of these regulations have imposed additional requirements that may affect both the Company and its derivatives counterparties, including in the areas of reporting, recordkeeping, the mandatory exchange execution and clearing of certain derivatives, position limits with respect to certain derivatives, regulatory initial margin and variation margin requirements, and limitations on the ability to close out certain derivatives transactions with certain counterparties upon the bankruptcy of such counterparties.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
However, failure to maintain a reasonable and effective data protection and cybersecurity program, or any compromise of the security, confidentiality, integrity, or availability of our information systems and the sensitive, proprietary, and confidential data, including personal information, on such systems could lead to additional costs and liabilities, as well as damage our reputation or deter people from purchasing our products.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
In addition, we expect to recognize approximately $800 We recognized $797.6 million of non-life NOLs on our tax return as a result of changes related to the tax accounting method for allocating indirect costs (pursuant to the Code) to self-constructed real estate assets upon approval from the IRS. Internal Revenue Service.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
The use or anticipated use of AI technologies, including generative AI, by us or third parties, may increase the operational risks discussed above, or create new or unanticipated operational risks.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedRisk Factors
Many of our competitors are larger companies that have greater capital, capital and technological and marketing resources and have access to capital at a lower cost. resources.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
Such NOLs will are not be subject to expiration.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
We intend to may make changes to certain NGEs in the future.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
The investment segment involves the management of our capital resources, including investments and the management of corporate debt and liquidity. Our measure of profitability of this segment is the total net investment income not allocated to the insurance products. Investment income not allocated to product lines represents net investment
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
business and a more meaningful analysis of results of our insurance product lines. The table above reconciles the non-GAAP measure to the corresponding GAAP measure.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
In February 2021, we acquired DirectPath, LLC ("DirectPath", now known as Optavise, LLC subsequent to its name change in April 2022). In April 2019, we acquired Web Benefits Design Corporation ("WBD"), which was subsequently merged into Optavise, LLC during 2023. Optavise, LLC provides personalized benefits education, advocacy and transparency, and communications services that help employers reduce healthcare costs and assist employees with making informed benefits decisions. Optavise, LLC goodwill and other intangible assets arising from the acquisitions were reflected in our Fee income segment.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
Macroeconomic, industry and market conditions, both current and future expected financial performance, and relevant entity-specific events that occurred during the three months ended September 30, 2025 caused us to consider whether there were any interim indicators of impairment related to the Optavise, LLC business within our fee income segment. Optavise, LLC provides personalized benefits education, advocacy and transparency, and communications services that help employers reduce healthcare costs and assist employees with making informed benefit decisions. As a result of this evaluation, we identified that the valuation of Optavise, LLC would more likely than not be impacted by the recent decline in value of comparable publicly traded companies. This, combined with lower than anticipated revenue in the quarter and trends for future periods led us to conclude that there were indicators of impairment and we accordingly prepared a quantitative assessment. The Company determined the fair value of the reporting unit by using a combination of the present value of expected future cash flows and a market approach based on earnings multiple data from peer companies, using unobservable level 3 inputs.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
As a result of the quantitative assessment performed, the Company concluded that goodwill of $69.5 million and other assets, primarily intangible assets, of $27.2 million were fully impaired as of September 30, 2025. We recognized an additional impairment charge of $5.2 million related to other long-lived assets as a result of exiting the fee services side of the Worksite business during the fourth quarter of 2025, as previously announced. The total impairment charge of $101.9 million is included in the accompanying consolidated statement of operations for the year ended December 31, 2025. No material assets remain on Optavise, LLC after the effect of these impairments.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
Operating return on equity ("operating ROE") (a non-GAAP measure) is equal to the trailing four quarters of net operating income divided by average shareholders' equity, excluding accumulated other comprehensive loss and net operating loss carryforwards. Our operating ROE, excluding significant items, was 11.4 percent, 11.4 percent, and 8.6 percent for the years ended December 31, 2025, 2024, and 2023, respectively. We continue to target an improvement in run‑rate operating ROE of 200 basis points through 2027, off a 2024 run-rate of approximately 10 percent.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
Net fee income decreased $14.8 million in 2025 as compared to 2024 primarily from decreased fee income recognized on Medicare Advantage third-party products, including unfavorable experience adjustments of $4.1 million in 2025 compared to favorable experience adjustments of $2.6 million in 2024. The experience adjustments are largely reflected in the first quarter. In addition, we updated our Medicare Advantage assumptions in the fourth quarter of 2025 to primarily reflect lower persistency, including higher exchanges between carriers, resulting in an unfavorable impact to income of $5.6 million.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
Beginning in the fourth quarter of 2025, as a result of exiting the fee services business within our Worksite Division, the net results of this business are no longer reflected within operating income, but are reflected within non-operating income.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
2025 2024 2023 Investment income not allocated: Excluding variable components: From general account assets $ 105.0 $ 129.2 $ 108.3 Other investment income 22.5 36.6 9.3 Spread income: FHLB program: Investment income 150.4 161.2 147.4 Interest expense (a) (111.2) (123.2) (104.7) Net spread income on FHLB program 39.2 38.0 42.7 FABN program: Investment income 151.7 96.7 59.0 Expenses (a)(b) (117.6) (64.0) (30.4) Net spread income on FABN program 34.1 32.7 28.6 Interest expense on corporate debt (a) (92.5) (91.8) (62.7) Interest expense on financing arrangements (a) (3.7) (4.7) (2.4) Total excluding variable components 104.6 140.0 123.8 Variable components: Net income from assets supporting deferred compensation plans: Investment income 28.8 27.9 28.7 Expenses (a) (26.7) (24.3) (22.2) Net income from assets supporting deferred compensation plans 2.1 3.6 6.5 Alternative investment income (loss): Total alternative income 64.5 13.6 (1.8) Allocated to product lines (22.9) (28.2) (30.5) Allocated to FABN program (0.7) (0.7) — Excess alternative investment income (loss) 40.9 (15.3) (32.3) Trading account income 5.7 4.9 6.5 Hedge variance related to fixed indexed products (a) 0.8 2.2 (2.5) Impact of annual option forfeitures related to fixed indexed annuity surrenders (a) 14.4 26.0 7.1 Impacts of change in projected cash flows, prepayment and call income and other 0.9 6.5 11.1 Total variable components 64.8 27.9 (3.6) Total investment income not allocated to product lines $ 169.4 $ 167.9 $ 120.2 Reconciliation to net investment income: Total investment income not allocated to product lines $ 169.4 $ 167.9 $ 120.2 Investment income on variable interest entities reported as non-operating income 23.3 33.5 74.8 Add back amounts reported as benefits and expenses 336.5 279.8 217.9 Change in market values of the underlying options supporting fixed indexed products 119.9 255.9 129.0 Amounts allocated to products 1,074.3 1,011.7 957.8 Net investment income $ 1,723.4 $ 1,748.8 $ 1,499.7
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
(b) Comprised of interest credited and amortization of deferred acquisition costs
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
Net change in market value of investments recognized in earnings 14.3 22.8 (6.3)
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
Changes in fair value of embedded derivative liabilities and market risk benefits (64.0) 46.3 (29.9)
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RemovedMD&A
In addition, management uses these non-GAAP financial measures in its budgeting process, financial analysis of segment performance and in assessing the allocation of resources. We believe these non-GAAP financial measures enhance an investor's understanding of our financial performance and allows them to make more
Read it in 10-K Feb 26, 2025 at sec.govopen_in_new
RemovedMD&A
The Code limits the extent to which losses realized by a non-life entity (or entities) may offset income from a life insurance company (or companies) to the lesser of: (i) 35 percent of the income of the life insurance company; or (ii) 35 percent of the total loss of the non-life entities (including NOLs of the non-life entities). There is no similar limitation on the extent to which losses realized by a life insurance entity (or entities) may offset income from a non-life entity (or entities).
Read it in 10-K Feb 26, 2025 at sec.govopen_in_new
RemovedMD&A
method for allocating indirect costs (pursuant to the Code) to self-constructed real estate assets upon approval from the IRS. Such NOLs will not be subject to expiration.
Read it in 10-K Feb 26, 2025 at sec.govopen_in_new
RemovedMD&A
During the fourth quarter of 2024, the Company performed a quantitative impairment assessment in accordance with ASC 350. As a result of this impairment test, we determined that the fair value of the Optavise reporting unit exceeded its carrying value and therefore, goodwill was not impaired.
Read it in 10-K Feb 26, 2025 at sec.govopen_in_new
RemovedMD&A
While future cash flows utilized in the quantitative impairment test are consistent with those that are used in our internal planning process, estimating cash flows requires significant judgment. Future changes to our projected cash flows can vary from the cash flows eventually realized, which may have a material impact on the outcomes of future goodwill impairment tests. The Company also uses a weighted average cost of capital that represents the blended average required rate of return for equity and debt capital based on observed market return data and company specific risk factors. The estimated fair value of the Optavise reporting unit is highly sensitive to changes in the weighted average cost of capital and terminal value estimates. For example, increasing the weighted average cost of capital by 300 basis points or decreasing the terminal value by 13 percent would result in the carrying value of the Optavise reporting unit exceeding its fair value, resulting in goodwill impairment.
Read it in 10-K Feb 26, 2025 at sec.govopen_in_new
RemovedMD&A
Net fee income decreased modestly in 2024 compared to 2023 due to: (i) changes in our revenue recognition assumptions related to sales of third-party Medicare Advantage products by our Consumer Division reflecting less favorable policy persistency and higher agent persistency resulting in higher renewal commissions; largely offset by (ii) higher sales of third-party Medicare Advantage products in 2024; and (iii) slightly lower losses related to services provided by Optavise and operations of our broker-dealer and registered investment advisor. Net fee income increased in 2023 primarily due to growth in the sales of third-party Medicare Advantage products by our Consumer Division and changes to our revenue recognition assumptions reflecting favorable policy persistency; partially offset by lower earnings related to services provided by Optavise.
Read it in 10-K Feb 26, 2025 at sec.govopen_in_new
RemovedMD&A
The interest margin was $2.3 million in 2024 compared to $2.8 million in 2023 and $3.3 million in 2022. The decline in the interest margin over the three year period is due to spread compression, partially offset by growth in the
Read it in 10-K Feb 26, 2025 at sec.govopen_in_new
RemovedMD&A
Amounts allocated to product lines and credited to policyholder account balances (1,265.4) (1,089.3) (709.9)
Read it in 10-K Feb 26, 2025 at sec.govopen_in_new
RemovedMD&A
Impact of annual option forfeitures related to fixed indexed annuity surrenders 26.0 7.1 (1.0)
Read it in 10-K Feb 26, 2025 at sec.govopen_in_new
RemovedMD&A
Amount related to variable interest entities and other non-operating items (33.5) (74.8) (48.5)
Read it in 10-K Feb 26, 2025 at sec.govopen_in_new
RemovedMD&A
Less amounts credited to deferred compensation plans (offsetting investment income) (24.3) (22.3) 13.4
Read it in 10-K Feb 26, 2025 at sec.govopen_in_new
RemovedMD&A
(b)This non-GAAP measure has been further adjusted for the expected repayment of the 2025 Notes, as described above in our 2025 Outlook. However, this measure does not replace the corresponding GAAP measure.
Read it in 10-K Feb 26, 2025 at sec.govopen_in_new
RewordedMD&A
Fixed indexed annuities Insurance policy income $ 27.6 $ 28.0 $ 19.7 $ 14.5 Net investment income 512.2 458.7 410.3 373.8 Insurance policy benefits (6.9) 14.2 (10.1) (20.0) Interest credited (242.3) (205.1) (161.9) (127.5) Amortization and non-deferred commissions (94.6) (80.0) (65.8) (57.4) Margin from fixed indexed annuities $ 196.0 $ 215.8 $ 192.2 $ 183.4 Average net insurance liabilities $ 10,582.5 $ 9,848.9 $ 9,337.3 $ 8,788.6 Margin/average net insurance liabilities 1.85 % 2.19 % 2.06 % 2.09 % Fixed interest annuities Insurance policy income $ 2.1 $ 1.2 $ 1.0 $ 0.8 Net investment income 86.9 84.1 83.6 83.0 Insurance policy benefits 0.7 0.1 (0.5) (1.1) Interest credited (48.5) (46.6) (45.2) (45.7) Amortization and non-deferred commissions (8.4) (7.2) (5.0) (4.6) Margin from fixed interest annuities $ 32.8 $ 31.6 $ 33.9 $ 32.4 Average net insurance liabilities $ 1,591.4 $ 1,578.3 $ 1,612.0 $ 1,700.5 Margin/average net insurance liabilities 2.06 % 2.00 % 2.10 % 1.91 % Other annuities Insurance policy income $ 9.6 $ 6.3 $ 7.7 $ 7.8 Net investment income 22.2 22.2 22.4 23.2 Insurance policy benefits (18.8) 0.9 (18.4) (17.2) Interest credited (2.7) (2.1) (2.3) (2.3) Amortization and non-deferred commissions (0.5) (0.5) (0.4) (0.5) Margin from other annuities $ 9.8 $ 26.8 $ 8.9 $ 11.1 Average net insurance liabilities $ 397.0 $ 422.3 $ 458.8 $ 481.7 Margin/average net insurance liabilities 2.47 % 6.35 % 1.94 % 2.30 % Total annuity margin $ 238.6 $ 274.2 $ 235.0 $ 226.9 Average net insurance liabilities $ 12,570.9 $ 11,849.5 $ 11,408.1 $ 10,970.8 Margin/average net insurance liabilities 1.90 % 2.31 % 2.06 % 2.07 %
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Interest-sensitive life Insurance policy income $ 193.4 $ 187.9 $ 181.1 $ 174.6 Net investment income 55.9 53.2 51.5 51.6 Insurance policy benefits (79.7) (71.8) (65.7) (75.2) Interest credited (53.2) (50.9) (48.7) (48.3) Amortization and non-deferred commissions (22.1) (20.5) (19.5) (23.2) Margin from interest-sensitive life $ 94.3 $ 97.9 $ 98.7 $ 79.5 Average net insurance liabilities $ 1,113.4 $ 1,067.2 $ 1,038.2 $ 1,018.0 Interest margin $ 2.7 $ 2.3 $ 2.8 $ 3.3 Interest margin/average net insurance liabilities 0.24 % 0.22 % 0.27 % 0.32 % Underwriting margin $ 91.6 $ 95.6 $ 95.9 $ 76.2 Underwriting margin/insurance policy income 47 % 51 % 53 % 44 % Traditional life Insurance policy income $ 728.5 716.8 $ 701.4 $ 684.8 Net investment income 95.2 93.9 93.3 90.3 Insurance policy benefits (488.5) (504.2) (504.3) (500.1) Interest credited (0.5) (0.6) (0.6) (0.7) Amortization and non-deferred commissions (88.9) (77.5) (66.3) (54.3) Advertising expense (67.7) (77.3) (92.5) (94.3) Margin from traditional life $ 178.1 $ 151.1 $ 131.0 $ 125.7 Margin/insurance policy income 24 % 21 % 19 % 18 % Margin excluding advertising expense/insurance policy income 32 34 % 32 % 32 % Total life margin $ 272.4 $ 249.0 $ 229.7 $ 205.2
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
(iii) an increase in reserves the impact of $100.7 million due to a change in valuation basis recorded directly to surplus (offset by a $93.5 million release of premium deficiency reserves reflected in operating income); the reinsurance transaction with our Bermuda reinsurance subsidiary described below; and (iv) an increase in required capital primarily due to growth of our insurance business and expansion of the FABN program.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
In June, September and December of 2024, Bankers Life issued funding agreements each to a series of the Trust in a principal amounts amount of $750.0 million, $400.0 $350 million and $450.0 $400 million, respectively. respectively, in September and December 2025 and $750 million, $400 million, and $450 million, respectively, in June, September and December 2024.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Other factors driving fluctuations include Such amounts will generally fluctuate from period to period based on the performance of our alternative investments (which are typically reported a one quarter in arrears); the earnings related to the investments underlying our COLI; the spread we earn from our FHLB investment borrowing and FABN programs; and the level of prepayment income (including call premiums) and trading account income. income; and the impact of annual option forfeitures related to fixed indexed annuity surrenders.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Corporate debt to total capital 42.3 33.6 % 34.0 42.2 % Corporate debt to total capital, excluding accumulated other comprehensive income (loss) (a) 26.2 % 32.1 % 23.1 % Corporate debt to total capital, excluding accumulated other comprehensive income 25.6 % N/A (loss), as adjusted for the expected repayment of the 2025 Notes (a) (b)
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
(i) insurance policy income; and (ii) net investment income allocated to the insurance product lines; less (i) insurance policy benefits and interest credited to policyholders; and (ii) (iii) amortization of deferred acquisition costs and present value of future profits, (iv) non-deferred commissions commissions; and (v) advertising expense.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
(i) CNO Bermuda Re's statutory economic capital and surplus is less than 150 percent of its ECR enhanced capital requirement at the end of any calendar quarter; or (ii) CNO Bermuda Re's liquid assets are insufficient to meet its contractual obligations to ceding insurers, in each case, unless Bankers Life one or more ceding insurers has provided notice of recapture pursuant to the terms of a modified coinsurance the applicable reinsurance agreement between it and CNO Bermuda Re. Re and such recapture will cause CNO Bermuda Re to meet (i) and (ii).
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
(v) the present value of future profits; and (vi) the value of unexpired options credited to insurance liabilities) were $10,582.5 million, $9,848.9 million, million and $9,337.3 million in 2025, 2024 and $8,788.6 million in 2024, 2023 and 2022, respectively, driven by deposits and reinvested returns in excess of withdrawals. 2023, respectively.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Effective In addition, effective October 1, 2024, we retain 100 percent of our long-term care new business as we discontinued ceding 25 percent of long-term care new business under a reinsurance agreement. agreement (this did not impact the inforce business that we previously ceded).
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
(vii) changes in the valuation allowance for deferred tax assets (x) gains or losses related to divested business, net of taxes; and other tax items; and (viii) (xi) other non-operating items including earnings attributable to variable interest entities, net of taxes ("net operating income," a non-GAAP financial measure) is important to evaluate the financial performance of the company, and is a key measure commonly used in the life insurance industry.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Insurance Excluding significant items primarily related to our comprehensive annual actuarial review, the insurance product margin was $1,040.0 $1,019.5 million, $959.0 $1,012.7 million and $936.5 $925.1 million in 2024, 2023 2025, 2024 and 2022, 2023, respectively.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
Quiet changesMD&A
Based on our assessment, we have concluded that it is more likely than not that all our net deferred tax assets of $791.4 $711.7 million will be realized through future taxable earnings.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
Quiet changesMD&A
Growth in the block is primarily being partially offset by spread compression driven by increased surrenders of higher spread products.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new